Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Anemia

  Free Subscription


09.10.2017

2 Am J Hematol
2 Ann Hematol
2 Blood
1 Br J Haematol
2 Haematologica
1 Int J Hematol
1 J Pediatr
4 J Pediatr Hematol Oncol
1 J Trop Pediatr
4 JAMA
1 Kidney Int
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Hematol

  1. GONZALES GF, Rubin de Celis V, Begazo J, Hinojosa MDR, et al
    Correcting the cut-off point of hemoglobin at high altitude favors misclassification of anemia, erythrocytosis and excessive erythrocytosis.
    Am J Hematol. 2017 Oct 6. doi: 10.1002/ajh.24932.
    PubMed     Text format    

  2. MARTINEZ C, Watson DJ, Shebl A, Wallenhorst C, et al
    Impact of screening and exclusion of high anti-A titer donors on the risk of hemolytic anemia with intravenous immunoglobulin treatment - a hospital-based cohort study in the US.
    Am J Hematol. 2017 Oct 6. doi: 10.1002/ajh.24931.
    PubMed     Text format    


    Ann Hematol

  3. HOUSTON BL, Jayakar J, Wells RA, Lenis M, et al
    A predictive model of response to erythropoietin stimulating agents in myelodysplastic syndrome: from the Canadian MDS patient registry.
    Ann Hematol. 2017 Oct 3. doi: 10.1007/s00277-017-3137.
    PubMed     Text format     Abstract available

  4. YANG N, Chen J, Zhang H, Dai Z, et al
    Horse versus rabbit antithymocyte globulin in immunosuppressive therapy of treatment-naive aplastic anemia: a systematic review and meta-analysis.
    Ann Hematol. 2017 Sep 30. doi: 10.1007/s00277-017-3136.
    PubMed     Text format     Abstract available


    Blood

  5. BERTHAUT I, Bachir D, Kotti S, Chalas C, et al
    Adverse effect of hydroxyurea on spermatogenesis in patients with sickle cell anemia after six months of treatment.
    Blood. 2017 Sep 28. pii: blood-2017-03-771857. doi: 10.1182/blood-2017-03-771857
    PubMed     Text format    

  6. KUNG C, Hixon J, Kosinski PA, Cianchetta G, et al
    AG-348 enhances pyruvate kinase activity in red blood cells from patients with pyruvate kinase deficiency.
    Blood. 2017;130:1347-1356.
    PubMed     Text format     Abstract available


    Br J Haematol

  7. DI MAGGIO R, Maggio A
    The new era of chelation treatments: effectiveness and safety of 10 different regimens for controlling iron overloading in thalassaemia major.
    Br J Haematol. 2017;178:676-688.
    PubMed     Text format     Abstract available


    Haematologica

  8. CLUZEAU T, McGraw KL, Irvine B, Masala E, et al
    Pro-inflammatory proteins S100A9 and TNFalpha suppress erythropoietin elaboration in myelodysplastic syndromes.
    Haematologica. 2017 Oct 5. pii: haematol.2016.158857.
    PubMed     Text format     Abstract available

  9. VENUGOPAL P, Moore S, Lawrence DM, George AJ, et al
    Self-reverting mutations partially correct the blood phenotype in a Diamond Blackfan Anemia patient.
    Haematologica. 2017 Sep 29. pii: haematol.2017.166678.
    PubMed     Text format    


    Int J Hematol

  10. UPANAN S, McKie AT, Latunde-Dada GO, Roytrakul S, et al
    Hepcidin suppression in beta-thalassemia is associated with the down-regulation of atonal homolog 8.
    Int J Hematol. 2017;106:196-205.
    PubMed     Text format     Abstract available


    J Pediatr

  11. JITRARUCH S, Fitzpatrick E, Deheragoda M, Deganello A, et al
    Autoimmune Liver Disease in Children with Sickle Cell Disease.
    J Pediatr. 2017 Jul 20. pii: S0022-3476(17)30885.
    PubMed     Text format     Abstract available


    J Pediatr Hematol Oncol

  12. RAMASWAMI A, Rosen DJ, Chu J, Wistinghausen B, et al
    Fulminant Liver Failure in a Child With beta-Thalassemia on Deferasirox: A Case Report.
    J Pediatr Hematol Oncol. 2017;39:235-237.
    PubMed     Text format     Abstract available

  13. PARAKH N, Chandra J, Sharma S, Dhingra B, et al
    Efficacy and Safety of Combined Oral Chelation With Deferiprone and Deferasirox in Children With beta-Thalassemia Major: An Experience From North India.
    J Pediatr Hematol Oncol. 2017;39:209-213.
    PubMed     Text format     Abstract available

  14. MENAKER N, Halligan K, Shur N, Paige J, et al
    Acute Liver Failure During Deferasirox Chelation: A Toxicity Worth Considering.
    J Pediatr Hematol Oncol. 2017;39:217-222.
    PubMed     Text format     Abstract available

  15. GAIT-CARR E, Connolly DJ, King D
    Moyamoya Syndrome Associated With Hereditary Spherocytosis: An Emerging Clinical Entity.
    J Pediatr Hematol Oncol. 2017;39:233-234.
    PubMed     Text format     Abstract available


    J Trop Pediatr

  16. NTENDA PAM, Chuang KY, Tiruneh FN, Chuang YC, et al
    Multilevel Analysis of the Effects of Individual- and Community-Level Factors on Childhood Anemia, Severe Anemia, and Hemoglobin Concentration in Malawi.
    J Trop Pediatr. 2017 Jul 27. doi: 10.1093.
    PubMed     Text format     Abstract available


    JAMA

  17. YU Z, Li T
    Ferric Carboxymaltose to Treat Isovolemic Anemia.
    JAMA. 2017;318:1281.
    PubMed     Text format    

  18. FUJITA T
    Effect of Different Iron Preparations for Young Children With Iron-Deficiency Anemia.
    JAMA. 2017;318:1282.
    PubMed     Text format    

  19. KIM YW, Yang H
    Ferric Carboxymaltose to Treat Isovolemic Anemia-Reply.
    JAMA. 2017;318:1281-1282.
    PubMed     Text format    

  20. POWERS JM, Buchanan GR, McCavit TL
    Effect of Different Iron Preparations for Young Children With Iron-Deficiency Anemia-Reply.
    JAMA. 2017;318:1282-1283.
    PubMed     Text format    


    Kidney Int

  21. MARCELLI D, Bayh I, Merello JI, Ponce P, et al
    Dynamics of the erythropoiesis stimulating agent resistance index in incident hemodiafiltration and high-flux hemodialysis patients.
    Kidney Int. 2016 May 10. pii: S0085-2538(16)30056.
    PubMed     Text format     Abstract available


    PLoS One

  22. COLOIGNER J, Kim Y, Bush A, Choi S, et al
    Contrasting resting-state fMRI abnormalities from sickle and non-sickle anemia.
    PLoS One. 2017;12:e0184860.
    PubMed     Text format     Abstract available

  23. OKUBO BM, Matos AG, Ribeiro Junior HL, Borges DP, et al
    Myelodysplastic syndrome patients present more severe respiratory muscle impairment and reduced forced vital capacity: Is disordered inflammatory signaling the culprit?
    PLoS One. 2017;12:e0184079.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: